Clinical Trials
70 trialsAMT-562 in Patients With Selected Advanced Solid Tumors
Multitude Therapeutics Inc.
Safety, Tolerability, Pharmacokinetics (PK), and Primary Clinical Efficacy of LY01616 in Patients With Advanced Solid Tumors
Luye Pharma Group Ltd.
BM201-1001
InnoBM Pharmaceuticals Co., Ltd.
Safety and Efficacy of IBI389 Single Agent, and in Combination With Sintilimab, in Patients With Advanced Malignancies
Innovent Biologics (Suzhou) Co. Ltd.
A Phase IB/II Clinical Study of SHR-A2009 for Injection in Combination With Other Antitumor Therapies in Patients With Advanced Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
A Study to Observe and Evaluate the Safety and Efficacy of c610 Injection for Treatment of Advanced Solid Tumor Patients
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
A Phase I First in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WGI-0301 in Patients With Advanced Solid Tumors
Zhejiang Haichang Biotech Co., Ltd.
A Study of QL1706H in Patients With Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.
Study of YH004 (4-1BB Agonist Antibody) in Advanced Solid Tumors And Relapsed Or Refractory Non-Hodgkin Lymphoma
Eucure (Beijing) Biopharma Co., Ltd
A Phase 1 Study of ASKG315 in Patients With Advanced Solid Tumors
AskGene Pharma, Inc.
Universal Dual-target NKG2D-NKp44 CAR-T Cells in Advanced Solid Tumors
Zhejiang University
IMM2510, a PD-L1 and VEGF Bispecific Fusion Protein, in Patients With Advanced Solid Tumors
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
A Study of Q-1802 in Patients With Advanced Solid Tumors
QureBio Ltd.
A Study of HRXG-K-1939 and Adebrelimab in Patients With Advanced Solid Tumors
Fudan University
Clinical Study of PM1003 in Phase I/IIa Treatment of Advanced Malignant Solid Tumors
Biotheus Inc.
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Evidence of Antitumor Activity of FHND5071 as a Single Agent in Adult Patients With Advanced Solid Tumors
Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.
A Study to Evaluate the Efficacy and Safety of QL1706 Injection in Patients With Solid Tumors
Qilu Pharmaceutical Co., Ltd.
Study of GEC255 in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation
GenEros Biopharma Ltd
A Study of ASKG315 in Patients With Advanced Solid Tumors.
AskGene Pharma, Inc.
Safety of PUR001 Monotherapy in Patients With Advanced Solid Tumors
Purinomia Biotech, Inc.
Evaluate the Safety, Tolerability, and Pharmacokinetics of ICP-723 in Patients With Advanced Solid Tumors
InnoCare Pharma Inc.
A Study of MRG003 in the Treatment of Patients With EGFR-positive Advanced or Metastatic Solid Tumors
Shanghai Miracogen Inc.
A Trial of Camrelizumab for Injection in Combination With Famitinib Malate Capsule and Paclitaxel For Injection(Albumin Bound) in Advanced Solid Tumors of Patients
Jiangsu HengRui Medicine Co., Ltd.
A Phase I Study of QL1604 in Subjects With Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.
Dose Escalation/Dose Expansion Study of YBL-006 in Patients With Advanced Solid Tumors
Y Biologics Inc.
A Study Evaluating SYHX2005 in the Treatment of Patients With Advanced Solid Tumors
CSPC Ouyi Pharmaceutical Co., Ltd.
A Phase I Clinical Study of SHR-A2009 for Injection in Patients With Advanced Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
A Phase 1b/2 Study of YL-13027 Combined With Sintilimab in Patients With Advanced Solid Tumors
Shanghai YingLi Pharmaceutical Co. Ltd.
A Clinical Study to Evaluate the Safety, Tolerability,JS019 in Patients With Advanced Solid Tumors
Suzhou Kebo Ruijun Biotechnology Co., Ltd
A Study of Duvelisib Combined With SG001 Injection in Patient With Advanced Solid Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
A Clinical Study to Evaluate the Safety and Tolerability of JS107 in Advanced or Metastatic Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
A Trial of the Combination of SHR-A1811 and Fluzoparib in HER2-Expressing Cancers
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
A Study to Evaluate the Efficacy and Safety of AK127 in Patients With Advanced Solid Tumors
Akeso
A Study of QLS31905 in Patients With Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.
A Study of Docetaxel Polymeric Micelles for Injection in Patients With Advanced Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd.
Study of Anti-5T4 CAR-NK Cell Therapy in Advanced Solid Tumors
Wuxi People's Hospital
Evaluation of the Safety and Efficacy of Albumin-bound Docetaxel
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
The Comparison of the Pharmacokinetics of Albumin-bound Docetaxel and Taxotere
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
A Study to Evaluate the Safety and Efficacy of Docetaxel for Injection (Albumin-bound)in Different Dose Regimens in Patients With Advanced Solid Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
A Study of Sirolimus for Injection (Albumin Bound) in Patients With Advanced Solid Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Evaluation of the Safety and Efficacy of NBL-015 in Patients With Advanced Solid Tumors
NovaRock Biotherapeutics, Ltd
A Phase Ib Study of Primary Efficacy and Safety of IBI321 Monotherapy or Combination Therapy in Patients With Advanced Solid Tumors
Innovent Biologics (Suzhou) Co. Ltd.
First in Human Dose Escalation Study of YL-13027 in Subjects With Advanced Stage Solid Tumors
Shanghai YingLi Pharmaceutical Co. Ltd.
A Study of SKLB1028 in Patients With Advanced Solid Tumor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
A Phase I Study of AL8326 in Advanced Solid Tumor
Advenchen Laboratories, LLC
Effect of High-fat Meal on the Pharmacokinetics of TQ-B3139 Capsules
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
FGFR4 Inhibitor EVER4010001 in Combination With PD-1 Inhibitor Pembrolizumab in Patients With Advanced Solid Tumors
EverNov Medicines (Zhuhai Hengqin) Co., Ltd
A Study of CSPCHA131 in Patients With Advanced Solid Tumor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
A Study to Evaluate the Tolerance and Pharmacokinetics of TQB2618 Injection in Subjects With Advanced Solid Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
MTD, Safety and Efficacy of NYH817G and NYH100P in Monotherapy and Combination in Patients With Advanced Solid Tumors
Haim Bio Co., Ltd.